Our Customers
Products & Pipeline
Science & DTx
For business
Solutions
Clinicians
Investors
About us
Contact us
FacebookTwitterLinkedinYouTube
NHS
US Payers
Payers

Powering tailored mental health pathways to deliver recovery at scale

Creating clinically validated treatments that are engaging, easy to use, and effective.

An illustration of 10 people.

Partnership benefits

ieso is partnering with U.S. health plans, healthcare systems and payer partners to develop, deploy and deliver clinically validated, digital therapies for the treatment of a range of mental health conditions.

By using robust clinical and mental health science, and cutting-edge AI, our clinically validated digital programs will solve for:

A check mark
Quality: A new “science” of mental health that brings outcomes in-line with physical health
A check mark
Access: Scalable products will improve at least 100m lives within 5 years
A check mark
Engagement: Next-generation digital solutions that can “listen” and provide tailored responses
A check mark
Affordability: Removing barriers to mental health treatment

Curious how our programs could fit into your workflow?

A positively different future of care

We offer partners, and those in their care, equitable access to quality digital behavioral health therapies, at scale.

By using deep learning to  ‘crack the code’ of 1 billion words of therapy, ieso’s artificial intelligence capability and unique clinical model drives advances, enabling us to launch advanced, evidence-based, digital behavioral health therapies that deliver sustainable psychological benefit.

Meet the team

Danah Tangen

SVP US Market Development

LinkedIn logo.
Connect with us on LinkedIn
Alyssa Dietz

Head of US Clinical Strategy

LinkedIn logo.
Connect with us on LinkedIn
Laura Carlin

Director of US Business Strategy and Operations

LinkedIn logo.
Connect with us on LinkedIn
Laurel Galaty

Head of Customer Success and Service Delivery

LinkedIn logo.
Connect with us on LinkedIn

Find out more

Join our email list to receive the latest news, research papers, and event updates.